| CMMC Neuroscience Center |
 |
Multiple Sclerosis |
Basic Information
Multiple sclerosis is an inflammatory disease of the brain
and spinal cord. It is a condition of recurring attacks (remitting-relapsing
phase), resulting in loss of neurologic function. Typical
attacks include sudden loss of strength, sensation, vision,
or loss of balance. The disease may enter a latter stage where
symptoms progress without resolving (secondary progressive).
It most often affects younger patients, in the 25 to 35-year-old
age group, however many patients in their 40s and 50s have
also been newly diagnosed. Multiple sclerosis is caused by
autoimmune (immune responses triggered against self) attacks
on the brain and spinal cord. The target is the myelin that
coats the brain fibers.
Symptoms
- Sudden loss of strength or sensation, often with recovery
over days or weeks
- Sudden loss of vision in one eye
- Sudden double vision, vertigo, or difficulty speaking
- Poor balance or loss of walking coordination, loss of
bladder control
- Slowly progressing loss of memory
Treatment Available
- Symptomatic treatment includes drugs to control bladder
contractions, increase energy, and relieve depression
- Corticosteroids are used for acute attacks, and will produce
rapid relief of acute symptoms
- Beta-interferons have emerged as an important treatment
to prevent long-term progression of the disease
- Glatiramer acetate is a compound that fools the immune
system and decreases inflammatory attacks
- Other immunosuppressive agents such as methotrexate, cyclophosphamide,
and azathioprine are used
- Novantrone is a chemotherapeutic agent used for worsening
MS despite other treatment
Research
- Studies to understand the cascade of events that lead
to autoimmunity
- Clinical studies to find new treatments, especially biologic
agents directed at the immune systems
- Genetic studies
- Environmental studies
- Studies to understand the ultimate trigger of multiple
sclerosis, as well as other factors that worsen the disease
Web Site: National
Multiple Sclerosis Society
|